Across markets, a structural shift is underway. People are living longer than previous generations, yet those additional years are not always spent in good health. At the same time, expectations around health are evolving. Individuals increasingly want not just treatment when something goes wrong, but ongoing insight into how their daily behaviours shape long-term outcomes.
This is not just a healthcare story. It is a business story.
Health is moving from a reactive, episodic model to a continuous, data-driven one. As that shift accelerates, organisations across sectors from insurance and life sciences to employers and technology providers are beginning to recognise that health is no longer a peripheral concern. It is becoming a core driver of cost, performance and long-term value.
At the centre of this shift sits a seemingly simple but transformative capability: continuous data. And increasingly, that data is being generated through wearables.

Longevity without alignment

Life expectancy has increased steadily across developed economies, but healthy life expectancy has not kept pace. The result is a growing gap between how long people live and how long they remain in good health.
For businesses, this creates a structural challenge. Costs extend over longer time horizons. Health-related risks become persistent rather than episodic. Productivity is affected across longer working lives.
This translates into tangible commercial pressures:

• Rising insurance and healthcare costs
• Increased absenteeism and presenteeism
• Greater variability in workforce performance
• Reduced predictability in long-term planning

Yet most systems remain fundamentally reactive. Health is addressed when issues arise, rather than managed continuously. This leads to late intervention, higher treatment costs and limited ability to influence outcomes early.
In a world where longevity is increasing, a reactive model is no longer economically sustainable.

The shift to continuous health

What is changing is not just the expectation of health, but the ability to measure it.
Advances in technology now allow health to be tracked continuously rather than periodically. Behavioural and physiological signals, such as movement, sleep, heart rate, and stress, can all be captured in real time, creating a dynamic and evolving picture of an individual’s health.
This changes the equation in three important ways:

• Health becomes observable, not inferred
• Risk becomes trackable, not estimated
• Behaviour becomes influenceable, not assumed

For organisations, this opens the door to actively managing outcomes rather than simply absorbing cost.

Wearables as the catalyst

Wearables are often viewed as consumer devices. They are becoming the data infrastructure that underpins continuous health.
Smartwatches, fitness trackers and similar devices generate high-frequency, real-world data at scale. Crucially, this data is both continuous and behavioural. It reflects what people do, not what they report or what is captured at isolated points in time.
This is what makes wearables commercially significant.
They create a feedback loop between behaviour, insight and intervention. Organisations can move from hindsight to foresight, identifying patterns early, prompting small behavioural changes and preventing more serious outcomes over time.

Accelerating medical breakthroughs through data

The most underappreciated impact of wearables is not just in prevention or engagement. It is in how they are reshaping the economics of medical research and innovation.
Traditionally, clinical research has been constrained by:

• Small, controlled sample sizes
• Infrequent data collection
• High costs of monitoring and follow-up
• Long timelines to generate statistically meaningful results

Wearables fundamentally change this model.
They enable continuous, real-world data collection across large populations, outside of clinical settings. Instead of periodic snapshots, researchers can access longitudinal datasets that capture how health evolves day by day, across diverse environments and behaviours.
This has several powerful implications:

1. Faster evidence generation
   Continuous data allows patterns to emerge more quickly. Subtle signals that would previously take years to detect can now be identified in shorter timeframes. This accelerates hypothesis testing and reduces the duration of studies.
2. Larger and more diverse datasets
   Wearables enable data collection at scale, across broader populations. This improves the robustness of findings and reduces bias associated with small or homogenous cohorts.
3. Reduced cost of trials
   Remote monitoring reduces the need for frequent in-person visits, lowering operational costs. Data can be collected passively, minimising the burden on participants and researchers alike.
4. Real-world evidence
   Data captured in everyday environments provides a more accurate reflection of how interventions perform outside controlled settings. This is increasingly valuable for regulators, payers and providers.
5. Continuous feedback loops
   Rather than waiting until the end of a trial, data can be analysed in near real time. This allows for adaptive study designs, earlier course correction and more efficient resource allocation.

Taken together, these factors have the potential to materially reduce both the time and cost required to bring new treatments, therapies and interventions to market.
For pharmaceutical and life sciences organisations, this is not incremental improvement. It is a step change in how innovation is delivered.

From cost management to value creation

Beyond research, wearables are reshaping core economic models.

Early intervention and cost reduction
Continuous monitoring allows organisations to identify risk earlier and intervene before conditions escalate. Small behavioural changes, improved sleep, increased activity, better stress management can compound over time, reducing the likelihood and severity of chronic conditions.
At scale, this translates into lower claims, reduced treatment costs and more efficient use of healthcare resources.

More precise risk management
Traditional risk models rely on historical data and broad segmentation. Wearables introduce real-time behavioural insight, enabling more granular and dynamic risk assessment.
This supports better forecasting, more aligned pricing and reduced uncertainty, particularly relevant in insurance and workforce management contexts.

New commercial models
Wearables also enable new revenue streams. Subscription-based health services, personalised coaching and outcome-based products become viable when continuous data is available.
Importantly, these models align commercial success with user outcomes. Sustained engagement leads to both better health and stronger economic performance.

Stronger engagement and retention
Because wearables are used daily, they create regular touchpoints. This drives ongoing engagement, reinforces behavioural change and builds longer-term relationships between organisations and users.
Engagement, in this context, is not a marketing metric. It is a driver of value.

Turning data into outcomes
However, data alone is not enough.
The organisations that will capture value are those that can translate data into action. This requires:

• Integration into broader healthcare and workplace systems
• Clear governance around data use, privacy and security
• Simple, actionable insights for users
• Alignment of incentives between individuals and organisations

Without this, data risks becoming noise rather than insight.

A structural shift, not a trend

There is a risk in viewing wearables as a marginal addition to existing models or as a short-term consumer trend.
They are a foundational component of a broader shift:

• From episodic to continuous engagement
• From reactive cost management to proactive value creation
• From static assessment to dynamic, data-driven decision making

For organisations, the question is no longer whether to engage with this shift, but how.
Those that treat wearables as a standalone product are unlikely to realise meaningful value. Those that embed them within wider operating models, linking data, behaviour, incentives and outcomes are better positioned to capture long-term benefit.

The business case for continuous health

Longevity is often framed as a challenge. In practice, it is also an opportunity, provided it is approached differently.
The ability to measure, understand and influence health continuously is changing how value is created across sectors. Wearables are not the end solution, but they are a critical enabler.
They allow organisations to move earlier, act more precisely and innovate faster. They reduce the cost of both care and discovery. And they align commercial outcomes with human outcomes in a way that traditional models have struggled to achieve.
This shift is already underway. The organisations that recognise its economic potential and act on it with clarity and discipline will be better positioned to deliver sustainable value in the years ahead.

About the author – Julie Crawford:

Julie spent 7 years at Accenture focusing primarily on Strategy, CRM and Process improvement projects within the travel industry. She went on to work for Carlson Wagonlit Travel for a further 7 years leading the EMEA Hotel Sourcing Group and UK Meetings and Events.